Healthy adults
Conditions
Interventions
Take one packet of the test food with water, warm water, green tea, or coffee before breakfast once a day. Dissolving the food in these solutions will be allowed.
Take one packet of the placebo food w
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Aged between 30 and less than 59 years old. 2. Japanese females. 3. Have anxiety about bone health. 4. BMI between 18.5 and 29.5 kg/m^2. 5. Can use smartphones or PCs to input an electronic diary. 6. Received sufficient explanation for the objective and summary of the trial, and voluntarily volunteered to the trial with the agreement of informed consent.
Exclusion criteria
Exclusion criteria: 1. Currently undergoing treatment for any disease, or receive medical treatment such as medical drugs or traditional Chinese medicines. Medications used as needed are acceptable. 2. Receiving nutritional and exercise therapy by medical doctors. 3. Have severe diseases or a history of severe diseases. 4. Received hormone replacement therapy within six months before the study. 5. Have experienced bone-related diseases such as bone fracture within six months before the study. 6. Have artificial materials or foreign substances in the bones with surgeries or any reason. 7. Have the Young Adult Mean% less than 70%. 8. Received barium swallow test within 7 days before the day of visit. 9. Have currently been taking commercially available drugs, quasi-drug products, foods, or supplements with any functional claims. However, can discontinue taking these drugs/foods during the trial period is acceptable to join the study. 10. Have allergies to drugs or foods. 11. Planning extremely change lifestyle (such as diet, sleep, or exercise) during the study period. 12. Planning travel to foreign countries during the study period. 13. Taking more than 60 g alcohol/day. 14. Smoking within one year before the trial. 15. Individuals who joined other clinical trials from one month before the trial, individuals who have currently been joined other clinical trials, and also Individuals who are planning to join other clinical trials during the trial. 16. Unsuitable for the study, that judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood bone metabolism-related markers Bone mineral density | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood metabolism assessment markers | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed